VIATRIS INC (VIA.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:VIA - US92556V1061 - Common Stock
VIA.DE Key Statistics, Chart & Performance
The current stock price of VIA.DE is 10.145 EUR. In the past month the price increased by 10.58%. In the past year, price decreased by -15.42%.
VIA.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.84 | 200.10B | ||
| 1SAN.MI | SANOFI | 10.75 | 198.47B | ||
| SAN.PA | SANOFI | 10.74 | 198.23B | ||
| MRK.DE | MERCK KGAA | 14.13 | 52.41B | ||
| UNC.DE | UCB SA | 37.51 | 46.84B | ||
| UCB.BR | UCB SA | 36.68 | 45.81B | ||
| BAYN.DE | BAYER AG-REG | 6.73 | 35.31B | ||
| 1BAYN.MI | BAYER AG-REG | 6.65 | 34.87B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.71 | 10.18B | ||
| IPN.PA | IPSEN | 11.68 | 10.06B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.48 | 9.30B | ||
| VIRP.PA | VIRBAC SA | 20.3 | 2.95B |
Related stock screener links
About VIA.DE
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Company Info
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA US
Employees: 32000
Phone: 17245141465
VIATRIS INC / VIA.DE FAQ
What does VIATRIS INC do?
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Can you provide the latest stock price for VIATRIS INC?
The current stock price of VIA.DE is 10.145 EUR.
Does VIATRIS INC pay dividends?
VIATRIS INC (VIA.DE) has a dividend yield of 3.92%. The yearly dividend amount is currently 0.41.
What is the ChartMill technical and fundamental rating of VIA stock?
VIA.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What do analysts say about VIATRIS INC (VIA.DE) stock?
17 analysts have analysed VIA.DE and the average price target is 10.84 EUR. This implies a price increase of 6.87% is expected in the next year compared to the current price of 10.145.
Can you provide the growth outlook for VIATRIS INC?
The Revenue of VIATRIS INC (VIA.DE) is expected to decline by -4.73% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for VIA stock?
VIATRIS INC (VIA.DE) will report earnings on 2026-02-25, after the market close.
VIA.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to VIA.DE. When comparing the yearly performance of all stocks, VIA.DE turns out to be only a medium performer in the overall market: it outperformed 53.09% of all stocks.
VIA.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VIA.DE. Both the profitability and financial health of VIA.DE have multiple concerns.
VIA.DE Financial Highlights
Over the last trailing twelve months VIA.DE reported a non-GAAP Earnings per Share(EPS) of 1.98. The EPS decreased by -14.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| Debt/Equity | 0.82 |
VIA.DE Forecast & Estimates
17 analysts have analysed VIA.DE and the average price target is 10.84 EUR. This implies a price increase of 6.87% is expected in the next year compared to the current price of 10.145.
For the next year, analysts expect an EPS growth of -10.8% and a revenue growth -4.73% for VIA.DE